Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Araújo, Joabe Lima | - |
Autor(es): dc.creator | Azevedo, Vitória Santos | - |
Autor(es): dc.creator | Araújo, Adrielle de Sá | - |
Autor(es): dc.creator | Araújo, Jessé Lima | - |
Autor(es): dc.creator | Araújo, Ingryde Lima | - |
Autor(es): dc.creator | Sousa, Lucas Aires de | - |
Autor(es): dc.creator | Santos, Gardênia Taveira | - |
Autor(es): dc.creator | Silva, Welson de Freitas | - |
Autor(es): dc.creator | Pinheiro, Ana Maria Alves | - |
Autor(es): dc.creator | Santos, Gabel Taveira | - |
Autor(es): dc.creator | Cruz, Hugo Vitor Menezes | - |
Autor(es): dc.creator | Passos, Ionara Nayana Gomes | - |
Autor(es): dc.creator | Rocha, Jefferson Almeida | - |
Data de aceite: dc.date.accessioned | 2024-10-23T16:01:54Z | - |
Data de disponibilização: dc.date.available | 2024-10-23T16:01:54Z | - |
Data de envio: dc.date.issued | 2021-01-07 | - |
Data de envio: dc.date.issued | 2021-01-07 | - |
Data de envio: dc.date.issued | 2020-06-30 | - |
Fonte completa do material: dc.identifier | https://repositorio.unb.br/handle/10482/39872 | - |
Fonte completa do material: dc.identifier | https://doi.org/10.37118/ijdr.19286.06.2020 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/898175 | - |
Descrição: dc.description | SARS-CoV-2 belongs to the Coronaviridae family and of the order Nidovirales, which has positive non-segmented RNA, of the enveloped type that causes a severe acute respiratory syndrome in humans, which has already infected more than 9 million people worldwide, leading to 496,075 deaths by June 27, 2020, making the search for alternative treatment for this pathogen urgent. Thus, this study aimed to conduct a bibliographic survey of research that presents treatment alternatives for the new coronavirus. Thus, a qualitative and descriptive cross-sectional study was carried out, and a comparative analysis was carried out with the prospective results achieved as presented in a study carried out by Reis and collaborators. Publications from the last 7 months were considered, that is, from December 2019 to June 2020, the period in which studies of SARS-CoV-2 started. In this way, a total of 4,898 studies related to the treatment alternative for SARS-CoV-2 were found, in which the drugs remdesivir, atazanavir, favipiravir, EIDD-2801 and hydroxychloroquine associated with azithromycin stand out, where they presented attractive preliminary results and are recommended for clinical studies in humans as an alternative way of coping with the new coronavirus. | - |
Formato: dc.format | application/pdf | - |
Publicador: dc.publisher | International Journal of Development Research | - |
Direitos: dc.rights | Acesso Aberto | - |
Direitos: dc.rights | Copyright © 2020, Joabe Lima Araújo et al., 2020. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | - |
Palavras-chave: dc.subject | SARS-CoV-2 | - |
Palavras-chave: dc.subject | Coronavirus | - |
Palavras-chave: dc.subject | Epidemias | - |
Palavras-chave: dc.subject | Covid-19 | - |
Palavras-chave: dc.subject | Tratamento | - |
Palavras-chave: dc.subject | Medicamentos | - |
Palavras-chave: dc.subject | Vacinas | - |
Título: dc.title | SARS-CoV-2 or Covid-19 : the search for alternative treatment for the new coronavirus | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional – UNB |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: